Eimeria arloingi in Goats: Caprine Coccidiosis in Kids, Diarrhea, Oocyst Identification, and Management

Etiology and Taxonomy of Eimeria arloingi

Eimeria arloingi is a protozoan parasite belonging to the phylum Apicomplexa, class Sporozoea, order Eucoccidiida, and family Eimeriidae. It is one of the most pathogenic species of caprine coccidia, primarily affecting goat kids. The species was originally described by Marotel in 1905 and later validated by Martin in 1909 [1]. The parasite exhibits a high degree of host specificity, with evidence demonstrating a failure to transmit the infection to lambs, confirming its adaptation to the domestic goat (Capra hircus) [1].

The endogenous development of E. arloingi involves a classic coccidian life cycle comprising asexual multiplication (merogony or schizogony) and sexual reproduction (gametogony) within the intestinal epithelium, followed by sporogony (sporulation) in the external environment [2, 1]. Detailed histopathological studies have localized the endogenous stages primarily to the jejunum and ileum, with meronts and gamonts developing within the absorptive epithelial cells [2, 3]. The prepatent period for E. arloingi has been documented at approximately 15 to 18 days post-infection [1]. Genetic characterization using 18S ribosomal RNA and internal transcribed spacer 1 (ITS-1) sequences has been employed to confirm species identity and assess phylogenetic relationships, particularly for isolates from geographically distinct regions such as Iran [4].

Epidemiology and Global Prevalence

Eimeria arloingi is a commonly identified species in goat herds worldwide. A systematic review and meta-analysis of global Eimeria species prevalence in goats reported an overall pooled prevalence estimate of 69.8% (95% CI: 58.7-79.8) across 127 studies, with E. arloingi consistently identified as one of the most prevalent species [5]. Specific regional prevalence studies highlight its widespread distribution. In Australian dairy goats, a molecular epidemiological investigation identified E. arloingi as a dominant species, with risk factors for infection including herd size, intensive management systems, and the presence of multiple age cohorts [6]. European studies have confirmed its presence in Poland, Western Pomerania, and Ukraine, where it is frequently co-detected with other Eimeria species [7, 8], as well as in the Czech Republic [9], the Netherlands [10], and Spain [11]. In Latin America, surveys from Brazil have demonstrated high infection rates in dairy goats raised under both intensive and semi-intensive systems [12, 13]. Prevalence is also well documented in Africa, including Zimbabwe [14], Nigeria [15], and Saudi Arabia [16], as well as in Southeast Asia, for example in peninsular Malaysia [17].

Risk factor analysis has identified several predisposing conditions for caprine coccidiosis. Management factors such as high stocking density, poor sanitation, damp bedding, and the commingling of multiple age groups on a single premises significantly increase the force of infection [18, 11]. Climatic conditions, particularly high ambient humidity and moderate temperatures, promote oocyst sporulation and environmental persistence [11]. Kid age is a critical factor; the highest oocyst excretion rates and most severe clinical disease occur in kids aged 3 to 8 weeks, coinciding with the waning of maternally derived immunity and the progressive exposure to contaminated environments [18].

Clinical Signs and Pathophysiology

The primary clinical manifestation of E. arloingi infection in goat kids is diarrhea. The pathophysiology of this diarrhea is multifactorial, stemming from the destruction of intestinal epithelial cells during merogony and gametogony. The disruption of the mucosal barrier leads to malabsorption of nutrients, increased intestinal permeability, and a protein-losing enteropathy. In an experimental model, infection with a novel caprine E. christenseni strain (closely related in clinical behavior to E. arloingi) produced similar pathological findings [19].

Clinical signs observed in experimental and natural caprine coccidiosis caused by E. arloingi include pasty to watery diarrhea, often discolored with mucus or frank blood, tenesmus, dehydration, anorexia, weight loss or poor growth rate, and dullness [19, 3]. Severely affected kids may exhibit a tucked abdomen, perineal fecal staining, and marked weakness. A notable comorbidity is the development of vitamin B12 deficiency in infected kids, which likely exacerbates the clinical condition by interfering with hematopoietic function and cellular metabolism [20].

The host immune response involves both innate and inflammatory mediators. Experimental infections have demonstrated dynamic changes in acute phase proteins, with significant elevations in haptoglobin and serum amyloid A observed during the acute phase of the disease [21]. Concurrently, alterations in inflammatory cytokines and mediators, including increased levels of nitric oxide and changes in pro-inflammatory and anti-inflammatory cytokine profiles, have been documented [22, 21]. These systemic responses contribute to the fever and malaise observed in clinical cases.

Pathology and Histopathology

Gross pathological findings in goats experimentally infected with E. arloingi are largely confined to the small intestine, particularly the jejunum and ileum. The intestinal wall is typically thickened, edematous, and congested. The mucosa may appear hyperemic, with petechial or ecchymotic hemorrhages. The intestinal contents are often watery, mucoid, or hemorrhagic [3, 1].

Histopathological examination reveals a spectrum of lesions ranging from focal enterocyte desquamation to widespread villous atrophy and fusion. Endogenous developmental stages, including meronts (schizonts) of various generations and gametocytes (macrogamonts and microgamonts), are found within parasitophorous vacuoles in enterocytes of the villar epithelium and, in heavy infections, within crypt epithelial cells [2, 3]. Electron microscopy has confirmed the ultrastructural features of these stages, including the formation of the parasitophorous vacuole, the development of rhoptries and micronemes in merozoites, and the elaboration of the oocyst wall during macrogametocyte maturation [3]. Inflammation in the lamina propria is characterized by infiltration of lymphocytes, plasma cells, macrophages, and, to a lesser extent, eosinophils and neutrophils [3].

Oocyst Identification and Diagnostic Methods

Accurate oocyst identification is a cornerstone of diagnosing caprine coccidiosis. The identification process relies heavily on the morphology, size, shape, and color of sporulated oocysts. For E. arloingi, the oocysts are typically ellipsoidal to ovoid and range from approximately 25 to 33 micrometers in length and 16 to 21 micrometers in width [2, 4, 23]. They are characterized by a smooth, colorless to pale yellow oocyst wall, the absence of a micropyle, and the presence of a distinct polar granule. Following sporulation, the oocyst contains four sporocysts, each enclosing two sporozoites [23].

Standard diagnostic approaches include:

1. Fecal Flotation: This is the most common screening method. A saturated salt or sugar solution (specific gravity approximately 1.20 to 1.25) is used to float oocysts from a homogenized fecal sample. The sample is examined microscopically under 100x to 400x magnification.
2. McMaster Counting Chamber: A quantitative modification of flotation that provides an estimate of oocysts per gram (OPG) of feces. OPG counts are essential for assessing infection intensity and determining the need for metaphylactic treatment. Values exceeding 5,000 to 10,000 OPG in kids are often associated with clinical disease.
3. Sporulation for Morphometric Identification: Fresh oocysts collected from fecal flotation are placed in a thin layer of 2% potassium dichromate (K2Cr2O7) solution at 25-30 degrees Celsius for 24-72 hours to induce sporulation. Morphometric measurement and observation of sporulation characteristics (e.g., presence or absence of a micropyle, Stieda body, polar granule, oocyst residuum) is performed using an ocular micrometer [23].
4. Molecular Differentiation: PCR amplification and sequencing of the ITS-1 region or 18S rRNA gene provides definitive species identification and is particularly useful for discriminating E. arloingi from morphologically similar species such as E. christenseni and E. ninakohlyakimovae [4]. This is increasingly important in epidemiological studies and for understanding mixed-species infections.

Differentiation from other caprine Eimeria species is critical. Species such as E. christenseni produce larger oocysts (often 40-50 micrometers), while E. ninakohlyakimovae produces smaller, sub-spherical oocysts [23]. The Respiratory and Intestinal Nematodes of Poultry represent a different class of parasites but underscore the importance of precise morphometric identification across different host species.

Management and Treatment Strategies

Management of caprine coccidiosis relies on an integrated approach combining chemoprophylaxis or metaphylaxis, management interventions, and passive immunization.

Anticoccidial Chemotherapy

Two major classes of anticoccidial drugs are evaluated in the literature for use in goat kids: triazine derivatives (toltrazuril and diclazuril) and sulfonamides.

Toltrazuril is a broad-spectrum anticoccidial that acts against both asexual and sexual stages of Eimeria species. Metaphylactic strategies using toltrazuril have proven effective in reducing oocyst shedding and the incidence of clinical diarrhea in goat kids. A single oral dose administered during the prepatent period (typically around 14 days of age) has shown high efficacy [24].

Diclazuril, another triazine derivative, is available as a feed additive or oral drench. Control strategies using diclazuril have demonstrated a significant reduction in oocyst output and lesion scores in experimentally infected kids [25].

Sulfonamides (e.g., sulfadimidine, sulfamethazine) are also used, but their efficacy can be variable. They are bacteriostatic in nature and require careful dosing to avoid toxicity. Their use is often reserved for treatment of active clinical disease rather than metaphylaxis.

Metaphylaxis and Strategic Dosing

The concept of metaphylaxis is central to controlling coccidiosis in goat kids. This involves administering an anticoccidial drug to a group of animals before clinical signs are expected to appear, based on known epidemiological risk periods. A recommended protocol includes:

• Timing: A single dose of toltrazuril or a course of diclazuril is administered to all kids in the cohort when the first cases of diarrhea are detected or at a predetermined age (e.g., 2 to 3 weeks old).
• Basis: This strategy is supported by evidence from controlled field trials showing that metaphylactic treatment reduces morbidity, mortality, and long-term growth impairment [24, 25].

Management Interventions

Environmental management is essential for reducing oocyst contamination. Key measures include:

• Hygiene: Daily removal of soiled bedding and manure in kid pens. Pens should be cleaned and disinfected between batches. Many common disinfectants are ineffective against coccidial oocysts; but steam cleaning, drying, and the use of ammonia-based compounds or phenolic disinfectants can be partially effective.
• Housing: Avoid overcrowding. Provide clean, dry, well-ventilated pens. Elevating slatted floors can reduce contact with feces.
• Feeding: Ensure kids receive adequate colostrum in the first 12-24 hours of life. Maintain a clean feeding area to minimize fecal-oral contamination.

Alternative and Supportive Therapies

Supportive care for clinically ill kids is critical. This includes fluid therapy (oral or intravenous) to correct dehydration and electrolyte imbalances, nutritional support, and potentially vitamin B12 supplementation in cases where deficiency is suspected [20]. The use of probiotics to modulate the gut microbiome is an area of active investigation but lacks robust clinical trial data for E. arloingi.

Innate Immunity and Inflammatory Response

The host reaction to E. arloingi infection involves a complex interplay of innate immune cells and soluble mediators. Following invasion of the intestinal epithelium, the release of merozoite antigens triggers an inflammatory cascade. This includes the recruitment of neutrophils and macrophages to the site of infection, followed by the activation of antigen-specific T lymphocytes.

In experimental caprine coccidiosis, dynamic patterns of systemic innate immunity have been characterized by fluctuations in pro-inflammatory cytokines such as tumor necrosis factor alpha and interleukin-1 beta, as well as anti-inflammatory cytokines like interleukin-10 [22]. The acute phase protein response, measured by changes in haptoglobin and serum amyloid A concentrations, correlates with the severity of intestinal damage and can serve as a biomarker for disease severity [21].

Control and Prevention Strategies

A comprehensive control program for E. arloingi must incorporate the following elements:

• Breeding Management: Maintain a closed or partially closed herd to minimize introduction of resistant isolates. Quarantine new animals and perform fecal examinations before introduction.
• Age Segregation: House kids separately from older goats to reduce the infective dose. Adults are frequently subclinical carriers and serve as a reservoir of infection.
• Immunity Management: Expose kids to a controlled, low-level infection after weaning to stimulate natural immunity, but only under conditions where clinical disease can be monitored and managed. This approach requires careful monitoring.
• Diagnostic Surveillance: Conduct routine fecal flotation and OPG counts on a representative sample of the kid cohort (e.g., 10-15 animals) at two-week intervals from 2 to 12 weeks of age. This allows for early detection of rising oocyst burdens and timely metaphylactic intervention.

A decision tree for managing Eimeria arloingi infections in goat kids is provided below.

graph TD
    A["Suspected Coccidiosis in Goat Kids"], > B["Fecal Sample for Flotation & OPG Count"]
    B, > C{"OPG > 10,000 OR Clinical Signs Present?"}
    C, Yes, > D["Confirm Eimeria arloingi via Morphology or PCR"]
    D, > E["Implement Metaphylaxis: Administer Toltrazuril or Diclazuril to Entire Cohort"]
    E, > F["Supportive Care: Fluids, Nutrition, Electrolytes"]
    F, > G["Environmental Control: Clean Pens, Dry Bedding, Reduce Stocking Density"]
    G, > H["Monitor Clinical Response & Recheck OPG in 7-10 Days"]
    H, > I{"Clinical Improvement & Reduced OPG?"}
    I, Yes, > J["Continue Preventive Management"]
    I, No, > K["Investigate for Mixed Infection, Secondary Pathogens, or Drug Resistance"]
    K, > L["Consider Alternative Anticoccidial or Adjunctive Therapy"]
    L, > M["Review Biosecurity & Herd Management Practices"]
    M, > H
    C, No, > N["Subclinical Infection: Manage Environment, Monitor Weekly"]
    N, > J

Differential Diagnosis

Diarrhea in goat kids has multiple etiologies, and E. arloingi must be distinguished from other enteric pathogens. Key differentials include bacterial infections such as Escherichia coli in Chickens and Poultry Products and other enteric bacteria adapted to goats, as well as viral agents like rotavirus and coronavirus (see Bovine Coronavirus in related ruminants). Cryptosporidium parvum, another apicomplexan parasite, is a common co-pathogen in neonatal kids and can be differentiated by the smaller size of its oocysts and the use of acid-fast staining or antigen detection assays. Nutritional diarrhea (e.g., from overfeeding milk replacer) is also a frequent consideration. Definitive diagnosis of E. arloingi relies on identifying the characteristic oocysts on fecal flotation and, if necessary, quantifying the burden via OPG counts.

Drug Resistance and Future Perspectives

The emergence of anticoccidial resistance in Eimeria populations is a growing concern. While specific resistance to toltrazuril or diclazuril in caprine E. arloingi has not been widely documented in the peer-reviewed literature, resistance has been reported in poultry coccidia and is considered a risk in goats. Strategies to delay resistance include rotational use of anticoccidials, avoiding underdosing, and integrating management practices that reduce the overall infective dose. Streptococcosis in Farmed Tilapia provides a parallel example of antimicrobial resistance management in animal agriculture.

Future research directions include the development of recombinant vaccines targeting immunogenic antigens of E. arloingi, although no commercial vaccine is currently available for caprine coccidiosis. The identification of parasite antigens that elicit protective immune responses is an active area of investigation. Additionally, the application of genomic and transcriptomic tools to characterize E. arloingi populations will improve our understanding of virulence factors and host-parasite interactions.

References

[1] Sayin F, Dincer S, Milli U. The life cycle and pathogenicity of Eimeria arloingi (Marotel, 1905) Martin, 1909, in Angora kids and an attempt at its transmission to lambs. Zentralbl Veterinarmed B. 1980. URL: https://pubmed.ncbi.nlm.nih.gov/7445833/

[2] Razavi SM, Hashemnia M, Khodakaram-Tafti A. Eimeria arloingi: further studies on the development of some endogenous stages. Exp Parasitol. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/24632189/

[3] Hashemnia M, Khodakaram-Tafti A, Razavi SM, et al. Experimental caprine coccidiosis caused by Eimeria arloingi: morphopathologic and electron microscopic studies. Vet Res Commun. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22127426/

[4] Khodakaram-Tafti A, Hashemnia M, Razavi SM, et al. Genetic characterization and phylogenetic analysis of Eimeria arloingi in Iranian native kids. Parasitol Res. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23779225/

[5] Ali EA, Ghafar A, Angeles-Hernandez JC, et al. Global prevalence of Eimeria species in goats: a systematic review and meta-analysis. Front Vet Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39916968/

[6] Ali EA, Ghafar A, Baxendell S, et al. Epidemiological insights into the prevalence of, and risk factors for, Eimeria species in Australian dairy goats. Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41765356/

[7] Balicka-Ramisz A, Ramisz A, Vovk S, et al. Prevalence of coccidia infection in goats in Western Pomerania (Poland) and West Ukraine region. Ann Parasitol. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/23444800/

[8] Balicka-Ramisz A. Studies on coccidiosis in goats in Poland. Vet Parasitol. 1999. URL: https://pubmed.ncbi.nlm.nih.gov/10206107/

[9] Koudela B, Boková A. Coccidiosis in goats in the Czech Republic. Vet Parasitol. 1998. URL: https://pubmed.ncbi.nlm.nih.gov/9650863/

[10] Borgsteede FH, Dercksen DP. Coccidial and helminth infections in goats kept indoors in the Netherlands. Vet Parasitol. 1996. URL: https://pubmed.ncbi.nlm.nih.gov/8720569/

[11] Ruiz A, González JF, Rodríguez E, et al. Influence of climatic and management factors on Eimeria infections in goats from semi-arid zones. J Vet Med B Infect Dis Vet Public Health. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/17010046/

[12] Cavalcante AC, Teixeira M, Monteiro JP, et al. Eimeria species in dairy goats in Brazil. Vet Parasitol. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/21852038/

[13] Freitas FL, Almeida Kde S, Nascimento AA, et al. [Species of the genus Eimeria Schneider, 1875 (Apicomplexa: Eimeriidae) in dairy goats maintained in intensive system in the São José do Rio Preto region, São Paulo State, Brazil]. Rev Bras Parasitol Vet. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/16153337/

[14] Chhabra RC, Pandey VS. Coccidia of goats in Zimbabwe. Vet Parasitol. 1991. URL: https://pubmed.ncbi.nlm.nih.gov/1957480/

[15] Woji AY, Little DA, Ikwuegbu OA. Prevalence of coccidial infections in the West African Dwarf goat in the subhumid zone of Nigeria. Trop Anim Health Prod. 1994. URL: https://pubmed.ncbi.nlm.nih.gov/8009644/

[16] Alyousif MS, Kasim AA, al-Shawa YR. Coccidia of the domestic goat (Capra hircus) in Saudi Arabia. Int J Parasitol. 1992. URL: https://pubmed.ncbi.nlm.nih.gov/1428514/

[17] Jalila A, Dorny P, Sani R, et al. Coccidial infections of goats in Selangor, peninsular Malaysia. Vet Parasitol. 1998. URL: https://pubmed.ncbi.nlm.nih.gov/9561704/

[18] Silva LMR, Carrau T, Vila-Viçosa MJM, et al. Analysis of potential risk factors of caprine coccidiosis. Vet Parasitol Reg Stud Reports. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33308721/

[19] Barba E, Molina JM, Rodríguez F, et al. Isolation of a Novel Caprine Eimeria christenseni Strain (GC) in Canary Islands and Analysis of Parasitological, Clinical, and Pathological Findings on Experimentally Infected Goat Kids. Animals (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39858138/

[20] Al-Habsi K, Ali H, Al-Kharousi K, et al. Vitamin B12 deficiency in newly weaned goat kids associated with clinical infection with Eimeria arloingi. Rev Bras Parasitol Vet. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33053054/

[21] Hashemnia M, Khodakaram-Tafti A, Razavi SM, et al. Changing patterns of acute phase proteins and inflammatory mediators in experimental caprine coccidiosis. Korean J Parasitol. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/22072820/

[22] Tadayon S, Razavi SM, Nazifi S. Dynamic Patterns of Systemic Innate Immunity and Inflammatory Associated Factors in Experimental Caprine Coccidiosis. Korean J Parasitol. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/28095656/

[23] Norton CC. Coccidia of the domestic goat Capra hircus, with notes on Eimeria ovinoidalis and E. bakuensis (syn. E. ovina) from the sheep Ovis aries. Parasitology. 1986. URL: https://pubmed.ncbi.nlm.nih.gov/3714300/

[24] Guedes AC, Conde-Felipe M, Barba E, et al. Metaphylactic strategies using toltrazuril against coccidiosis in goat kids. Vet Parasitol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38266373/

[25] Ruiz A, Guedes AC, Muñoz MC, et al. Control strategies using diclazuril against coccidiosis in goat kids. Parasitol Res. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22193521/